Trxade Group (NASDAQ: MEDS), an integrated
drug-procurement, delivery and healthcare platform, recently announced its
uplisting to the Nasdaq Capital Market and rang the opening bell on Friday,
Feb. 28, 2020. An article discussing the company reads, “‘We’ve been
under the radar for a long time. We’re trying to create visibility among the
investor base by doing the right thing,’ CEO Suren Ajjarapu stated late last
year following completion of an agreement between its subsidiary Bonum Health
and Benzer Pharmacy to create a network of ‘Bonum Health Hub’ units in small towns
and rural areas as part of the lead-up to the Nasdaq listing (http://ibn.fm/cO5VE). . . . The
company recently completed a firm-commitment public offering of 806,452 shares
of its common stock following a voter-approved reverse stock split. Trxade
expects to gain gross proceeds of $5.2 million from the sale of common stock in
the offering, minus standard expenses tied to the offering.”
To view the full article, visit http://ibn.fm/OEoeS
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group Inc. (NASDAQ:
MEDS) is an integrated drug-procurement, delivery and healthcare platform that
enables price transparency and increased profit margins to healthcare buyers
and sellers of pharmaceuticals. Founded in 2010, Trxade Group is comprised of
three synergistic operating platforms; the Trxade B2B trading platform with
11,900 registered pharmacies; and licensed virtual wholesale and mail-order
pharmacy-delivery capabilities using DelivMeds app. For additional information,
please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates
relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
